Key terms
About CGEM
Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CGEM news
Apr 18
12:28am ET
Strategic Shift and Promising Data Underpin Buy Rating for Cullinan Management’s CLN-978
Apr 17
7:11am ET
Cullinan Therapeutics price target raised to $30 from $20 at BTIG
Apr 16
8:16pm ET
Buy Recommendation: Cullinan Management’s Strategic Position in Autoimmune Disease Market with Promising CLN-978 Therapy
Apr 16
1:30pm ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cullinan Management (CGEM), Johnson & Johnson (JNJ) and UnitedHealth (UNH)
Apr 16
12:45pm ET
Cullinan Management’s Promising Clinical Developments and Financial Prospects Warrant a Buy Rating
Apr 16
12:05pm ET
Cullinan Therapeutics’ Strategic Pivot to Autoimmune Diseases and Promising Outlook for CLN-978 Spurs Buy Rating
Apr 16
11:53am ET
Cullinan Oncology price target lowered to $29 from $34 at H.C. Wainwright
Apr 16
7:32am ET
Cullinan Management’s Strategic Shift and Capital Raise
Apr 16
7:13am ET
Cullinan Oncology changes name to Cullinan Therapeutics
Apr 16
7:13am ET
Cullinan Oncology announces strategic expansion into autoimmune diseases
Apr 16
7:03am ET
Cullinan Therapeutics announces oversubscribed $280M private placement
Apr 15
8:44am ET
Cullinan initiated with Outperform on oncology portfolio at William Blair
Apr 15
5:45am ET
Cullinan Oncology initiated with an Outperform at William Blair
Mar 19
2:00am ET
Analysts Are Bullish on These Healthcare Stocks: Cullinan Management (CGEM), Gilead Sciences (GILD)
Mar 14
3:40pm ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Urogen Pharma (URGN) and Cullinan Management (CGEM)
Mar 14
1:40pm ET
Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Coherus Biosciences (CHRS) and Autolus Therapeutics (AUTL)
Mar 14
12:25pm ET
Cullinan Management: A Buy Rating on Strong Financials and Promising Clinical Trials
Mar 14
12:16pm ET
Cullinan Oncology announces departure of CFO Jeff Trigilio
Mar 01
7:04am ET
Cullinan Oncology announces U.S. FDA clearance of IND for CLN-619
Feb 15
8:12am ET
Wedbush bullish on Cullinan Oncology, initiates with an Outperform
Feb 14
4:05pm ET
Cullinan Oncology initiated with an Outperform at Wedbush
Jan 22
2:02pm ET
Buy Rating Affirmed: Cullinan Management’s Innovative Pipeline Promises Market Disruption and Strategic Growth
No recent press releases are available for CGEM
CGEM Financials
Key terms
Ad Feedback
CGEM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CGEM Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range